FDA panel votes against MDMA for PTSD, setting up hurdle to approval
CBSN
Potential approval of MDMA to treat post-traumatic stress disorder hit a major hurdle Tuesday, as a panel of the Food and Drug Administration's outside advisers voted against the treatment.
The committee voted nine against, two in favor, on the question of whether there was enough data to show the drug was effective in treating PTSD. The drug, which doctors call midomafetamine, is sold illegally as the street drug ecstasy.
While the FDA is not required to follow the committee's votes, agency officials often follow the panel's feedback. Sometimes drugmakers end up having to run different studies before they resubmit for the FDA's approval.
Washington — An independent panel tasked with reviewing the July assassination attempt against former President Donald Trump in Butler, Pennsylvania, found the Secret Service suffers from "deep flaws" that enabled the attack at the Trump campaign rally, and called for the agency to undergo "fundamental reform" to carry out its mission of protecting top government officials around the world.
There is a new wave of calls for Congress to return to Washington to respond to the growing costs of Hurricanes Helene and Milton. Multiple members of Congress from hurricane-ravaged states have issued new calls for the U.S. House and Senate to respond to the depletion of funds from the U.S. Small Business Administration disaster loan fund.